PaulosLab Profile Banner
Paulos Lab Profile
Paulos Lab

@PaulosLab

Followers
2K
Following
5K
Media
600
Statuses
3K

T cell specialists lab! @EmorySurgery @WinshipAtEmory

Atlanta, GA
Joined May 2011
Don't wanna be here? Send us removal request.
@PaulosLab
Paulos Lab
2 years
RT @PaulosLab: Check out Dr. @GuillermoORang1's new Cancer Research paper. We show that not all stem-like memory CD8 T cells are equal. ….
0
3
0
@PaulosLab
Paulos Lab
2 years
Check out Dr. @GuillermoORang1's new Cancer Research paper. We show that not all stem-like memory CD8 T cells are equal. Progressively enhancing stemness of adoptively transferred T cells with PI3Kδ blockade improves metabolism and anti-tumor immunity
1
3
29
@PaulosLab
Paulos Lab
2 years
RT @jessica_konen: Excited to announce that this manuscript is officially out in the latest issue of JCI! Thanks again to all the coauthors….
0
5
0
@PaulosLab
Paulos Lab
2 years
This! Please consider donating to our colleague in her time of need.
@GuillermoORang1
Guillermo O. Rangel Rivera
2 years
Friends and colleagues, our talented and hardworking technician, Soundharya needs your help! Please help us fundraise for her and her family in her time of need! .Share/donate! Any bit will help!.Fundraiser for Soundharya Kumaresan
0
0
1
@PaulosLab
Paulos Lab
2 years
RT @heykahn: If you're not using AI, you're falling behind. Here are 20 AI tools to future-proof yourself. Get more tools like this by si….
0
3K
0
@PaulosLab
Paulos Lab
2 years
☀️A must read by our MSTP student @GuillermoORang1! The degree of T cell stemness differentially impacts the potency of adoptive cancer immunotherapy in a Lef-1 and Tcf-1 dependent manner.
Tweet card summary image
biorxiv.org
Generating stem memory T cells (TSCM) is a key goal for improving cancer immunotherapy. Yet, the optimal way to modulate signaling pathways that enrich TSCM properties remains elusive. Here, we...
0
2
6
@PaulosLab
Paulos Lab
3 years
⭐️A must read!!! Congrats to @LesinskiLab & team for stellar work in novel immunotherapy to impact #PancreaticCancer. Just out in @JCI_insight: @sitcancer @ImmunologyAAI @WinshipAtEmory.
0
0
6
@PaulosLab
Paulos Lab
3 years
We @PaulosLab honored to be #JITCTop10 for this coolio B cell ACT CD8 T cell paper. ;).
@jitcancer
Journal for ImmunoTherapy of Cancer
3 years
Countdown to 2023: #JITCTop10 - B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity @Aubrey_Smith04 @PaulosLab
Tweet media one
0
1
38
@PaulosLab
Paulos Lab
3 years
Set your life on fire. Seek those who fan your flames. -Rumi.
0
1
8
@PaulosLab
Paulos Lab
3 years
CD40 agonism may circumvent a dysfunctional CD4 compartment to improve PD-1 blockade responsiveness, supporting a novel synergistic immunotherapeutic approach.
0
4
23
@PaulosLab
Paulos Lab
3 years
Great work from @Zihai and lab.
0
0
3
@PaulosLab
Paulos Lab
3 years
Increased numbers of neutrophils and macrophages associated with cancer progression may be risk factors for anaphylaxis.
0
0
2
@PaulosLab
Paulos Lab
3 years
The best of the best of the best, herein!! Woot @AyanaTRuffin.
@AyanaTRuffin
Dr.YayaTheScientist
3 years
#BIIW22 #BlackInImmunoRollCall.Hi there! I’m Ayana and I am a postdoc fellow in the @PaulosLab at @WinshipAtEmory . I am currently obsessed with B cells and their best friend CD4 T cells and how we might use both in adoptive cell therapy to treat cancer.
Tweet media one
0
0
5
@PaulosLab
Paulos Lab
3 years
RT @Chrystal_Paulos: 💥Less is more: @MeganMWyatt’s new manuscript in @biorxivpreprint shows metabolically fit CAR T cells can be generated….
0
4
0
@PaulosLab
Paulos Lab
3 years
‘Wolde ye bothe eate your cake, and haue your cake?’.-John Heywood, 1546.Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Adoptive cellular immunotherapy (ACT) is a potentially curative therapy for patients with advanced cancer. Eradication of tumor in mouse models and humans correlates with both a high dose of adopti...
2
5
20
@PaulosLab
Paulos Lab
3 years
RT @Chrystal_Paulos: The ⁦@PaulosLab⁩ is VERY thrilled to welcome our #gamechanger postdoc fellow ⁦@AyanaTRuffin⁩ to ⁦@EmoryUniversity⁩ ⁦@….
0
3
0
@PaulosLab
Paulos Lab
3 years
RT @WinshipAtEmory: #ASCO22 | June 3 | Education Session | Developmental Therapeutics."Tebentafusp for Uveal Melanoma".Panel Speaker: Melin….
0
4
0